MedPath

NUBEQA

NUBEQA

Approved
DIN Number

02496348

Drug Class

Human

Market Date

Mar 24, 2020

Company
HC

Bayer Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02496348
AIG Number0162034001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BB06 DAROLUTAMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DAROLUTAMIDEActive
Strength: 300 MG
Monograph: DAROLUTAMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.